# NBP in Adult Patients With Acute Ischemic Stroke (AIS)

> **NCT02905565** · PHASE2 · COMPLETED · sponsor: **CSPC-NBP Pharmaceutical Co., Ltd.** · enrollment: 177 (actual)

## Conditions studied

- AIS

## Interventions

- **DRUG:** NBP Softgel Capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02905565
- **Lead sponsor:** CSPC-NBP Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-28
- **Primary completion:** 2020-08-07
- **Final completion:** 2020-08-07
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02905565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02905565, "NBP in Adult Patients With Acute Ischemic Stroke (AIS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02905565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*